UNSPSC 51282523: Cefalexin monohydrate

This classification denotes a cephalosporin antibiotic with the molecular structure C16H17N3O4S.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, OBN7UDS42Y chemically known as (6r,7r)-7-((r)-2-amino-2-phenylacetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid monohydrate, but more commonly known as cephalexin, which bears US NIH Compound Identifier 2666. European Medicines Agency schedules Cephalexin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06165MIG.

Most nations, for tariff and trade purposes, schedule cefalexin monohydrate under HS 29419000. SMILES: CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)[C@@H](C3CCCCC3)N)SC1)C(=O)O.O.

UNSPSC 51282523 Cefalexin monohydrate (Commodity) represents pharmaceutical procurement activity that diverges sharply from the code's specific product focus. State and local solicitations tagged under this code encompass a broader pharmaceutical and medical supply acquisition landscape rather than cefalexin monohydrate purchases alone. Recent opportunities show state and local governments buying naloxone and drug deactivation systems, generic multi-source pharmaceuticals through cooperative purchasing vehicles, medical and first aid supplies for emergency response units, and direct-to-manufacturer prescription fulfillment programs. Issuing bodies include county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS), municipal fire and rescue divisions (City of Tampa), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP, serving Minnesota, Oregon, and participating jurisdictions). The activity reflects procurement supporting community health initiatives, emergency medical response, and state employee health plans rather than procurement of a single antibiotic product line.

Geographic activity spans Florida, Texas, Minnesota, and Oregon based on recent solicitations. Representative opportunities include Seminole County's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries and a two-year term plus one-year renewal option; the City of Tampa's sealed-bid solicitation 26P00145 (posted March 25, 2026, due March 13, 2026) for 169 line items of medical and first aid supplies for the Fire Department Rescue Division, estimated at $700,000 and designated as sheltered market for Small Local Business Enterprises with a 5 percent bid discount; MMCAP's RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through authorized wholesalers with awards effective July 1, 2026; and the Texas HHS Commission's RFI HHS0017013 (posted April 3, 2026, due April 3, 2026) exploring direct-to-manufacturer prescription programs. The code shows limited relevance to cefalexin monohydrate specifically; recent activity reflects broader pharmaceutical and medical supply sourcing rather than single-drug commodity procurement.